Rehabilitation and recovery in schizophrenia.

Rehabilitation and recovery in schizophrenia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Rehabilitation and recovery in schizophrenia. Abstract Text:

Dawn I Velligan,Jodi M Gonzalez,

The combination of new medications and effective psychosocial rehabilitation interventions has the potential to improve outcomes for individuals with schizophrenia significantly. Patients who have persistent positive symptoms can benefit from cognitive behavior therapy. Impairments in social competence can be addressed with social skills training. Supported employment programs may increase the ability of patients who have schizophrenia to obtain competitive employment. Family psychoeducational approaches, treatments for comorbid substance abuse, and cognitive rehabilitation approaches that enhance or bypass impairments in cognitive functioning are discussed. This article describes current efforts to incorporate these evidence-based principles of rehabilitative medicine into the management of schizophrenia.

Rehabilitation and recovery in schizophrenia. Publishing Authors By Initials

DI Velligan,JM Gonzalez,

For similar disorders of environmental origin: substance-related disorders research abstracts see: disorders of environmental origin: substance-related disorders research

PUBMED ID PMID:

MEDLINE DATE:

Rehabilitation and recovery in schizophrenia. Journal Published:

PUBLICATION TYPE: Review

Journal: The Psychiatric clinics of North America

VOLUME: 30

Page Numbers: 535-48

Journal Abbreviation: Psychiatr. Clin. North Am.

ISSN: 1558-3147

DAY: 21

MONTH: Sep

YEAR: 2007

Rehabilitation and recovery in schizophrenia. Information

Number of References: 80

LANGUAGE: eng

NlmUniqueID: 7708110

Rehabilitation and recovery in schizophrenia. Keywords Mesh Terms:

KEYWORDS: Substance-Related Disorders

MESH TERMS: therapy

Chemical & Substance for Abstract: Rehabilitation and recovery in schizophrenia. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Rehabilitation and recovery in schizophrenia.

AFFILIATION: Department of Psychiatry, Division of Schizophrenia and Related Disorders-MSC 7792, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA. velligand@uthscsa.edu <velligand@uthscsa.edu>

Country: United States

AGENCY: United States NIMH

GRANT: R01 MH074047–01A1

ACRONYM: MH

MEDLINETA: Psychiatr Clin North Am

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Rehabilitation and recovery in schizophrenia Related Publications

• A Family-Based Intervention Strategy for Addressing Childhood Obesity in an At-Risk Population: 1354: Board #117 May 30 9:30 AM - 11:00 AM.
• Adaptive model of the gradient index of the human lens. I. Formulation and model of aging ex vivo lenses.
• Beach morphodynamics forcements in oiled shorelines: Coupled physical and chemical processes during and after fuel burial.
• Biological research on drug abuse and addiction in Hispanics: current status and future directions.
• Citrate metabolism by Enterococcus faecium and Enterococcus durans isolated from goat's and ewe's milk: influence of glucose and lactose.
• Disease evolution of patients with mycosis fungoides--a report of 30 cases.
• Evaluation of the quality of the water in El Hondo natural park located in the east of Spain.
• Evolution of the amygdaloid complex in vertebrates, with special reference to the anamnio-amniotic transition.
• Genetic characterization of 2,4,6-trichlorophenol degradation in Cupriavidus necator JMP134.
• Human infection by Angiostrongylus costaricensis in Venezuela: first report of a confirmed case.
• Identification of ethanol responsive domains of adenylyl cyclase.
• Inbreeding and Reproduction in Endangered Ungulates: Preservation of Genetic Variation through the Organization of Genetic Resource Banks.
• Involvement of specific laminins and nidogens in the active remodeling of the basal lamina of labial salivary glands from patients with Sjögren's syndrome.
• Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation.
• Mouse lung CYP1A1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
• New trends in first-line treatment of non-small cell lung cancer: combinations without platinum.
• Noninvasive evaluation of allergic and irritant contact dermatitis by in vivo reflectance confocal microscopy.
• P2Y2 receptors induced cell surface redistribution of alpha(v) integrin is required for activation of ERK 1/2 in U937 cells.
• Parathyroid hormone assay: problems and opportunities.
• Pathology findings and validation of gastric and esophageal cancer cases in a European cohort (EPIC/EUR-GAST).
• Pharmacological study of uzarigenin-glucoside-canaroside.
• Phosphodiesterase type 5 inhibitors for the treatment of male lower urinary tract symptoms.
• Polymorphism in the 3' UTR of the IL12B gene is associated with Chagas' disease cardiomyopathy.
• Rehabilitation and recovery in schizophrenia.
• Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice.
• Src and Pyk2 mediate angiotensin II effects in cultured rat astrocytes.
• The PREgnane X receptor gene-humanized mouse: a model for investigating drug-drug interactions mediated by cytochromes P450 3A.
• [Caffeine inhibits chemoreceptor responses to hypoxia.]
• [Effects of the implementation of Universal Access with Explicit Guaranties (AUGE) Plan on the quality of care of patients with terminal renal failure]
• [Moonlighting physicians: analysis of its causes and consequences.]